Ibritumomab Intravenous and Von Willebrand factor recombinant
Determining the interaction of Ibritumomab Intravenous and Von Willebrand factor recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Von willebrand factor recombinant Intravenous
- Ibritumomab Intravenous-Vonvendi
- Ibritumomab Intravenous-Vopac
- Ibritumomab Intravenous-Vopac MDS
- Ibritumomab Intravenous-Vorapaxar
- Ibritumomab Intravenous-Vorapaxar Sulfate
- Von Willebrand factor recombinant-Ibritumomab Tiuxetan
- Von Willebrand factor recombinant-Ibrutinib
- Von Willebrand factor recombinant-Ibrutinib Capsules
- Von Willebrand factor recombinant-Ibrutinib Tablets
- Von Willebrand factor recombinant-Ibu
- Von Willebrand factor recombinant-IBU Tablets